SAN JOSE - Alexander Hawes, LLP, a well-established national class action and personal injury law firm, was among the very first to file a class action lawsuit against Guidant, Corporation, Inc. and Endovascular Technologies, Inc., arising from the defective Ancure Endograft System. The class action lawsuit, filed in the United States District Court for the Northern District of California, seeks to represent individuals and family members of individuals who have been implanted with the Ancure Device.

The Ancure Device was once touted as an alternative to the traditional surgery performed on persons suffering from abdominal aortic aneurysms (aaa). Yet, recent published reports indicate that at least 12 people have died as a result of malfunctions with the Ancure Endograft, and there were at least 57 unreported cases of emergency surgery due to this device. Over 2600 of these devices have malfunctioned in some fashion, out of a total of 7500 sold in the first 19 months of its introduction in the market.

Endovascular Technologies, Inc. recently agreed to pay a fine in excess of $92 million for misleading the FDA and the general public regarding the safety and efficacy of the Ancure Endograft System. And on June 16th, Guidant announced that it will discontinue the Ancure Endograft product, and will shut down their entire Menlo Park-based "Endovascular Technologies" operation.

"The fact is that product is unsafe, defective, and dangerous -- and Endovascular was covering all of this up," says Richard Alexander, a partner at Alexander Hawes, LLP.

The plaintiff in the present case is a 70-year old widow whose husband died as a result of complications apparently associated with the defective Ancure Endograft System.

For more information about this lawsuit, contact Alexander Hawes, LLP

BACK TO ANCURE PAGE.